Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?
Anejaculatory infertility due to multiple sclerosis.
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.
Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.
The influence of ethnicity on the characteristics of multiple sclerosis: A local population study between Persians and Arabs.
Genmab announces details of planned ofatumumab Phase II study in multiple sclerosis
Early bilateral cystoid macular oedema secondary to fingolimod in multiple sclerosis.
Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
Benefit of additional screening for progressive multifocal leukoencephalopathy in patients with multiple sclerosis taking natalizumab: a decision analysis.
[Epidemiology of multiple sclerosis in the Primosky Krai and Far East regions.]
Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.
Physiopathology of symptoms and signs in multiple sclerosis.
Amiloride Clinical Trial In Optic Neuritis (ACTION)
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.
Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon.
ONO-4641 Met Primary Endpoint of Phase II Study in Multiple Sclerosis Patients
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
3D models of human ERα and ERβ complexed with coumestrol.
Memory rehabilitation for people with multiple sclerosis.
Extracranial Venous abnormalities: A true pathological finding in patients with multiple sclerosis or an anatomical variant?
Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) (ALLEGRO)
Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis.
A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JC virus testing.

Pages